NCT02238236已完成不适用
Post Marketing Surveillance of Alesion® (Epinastine Hydrochloride) Dry Syrup -Drug Use-Results Survey of Alesion® Dry Syrup-
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 3,793
- 主要终点
- Incidence of adverse drug reactions
研究概览
简要总结
Study to investigate the safety and efficacy of Alesion® Dry Syrup under the proper use in daily clinical practice in Japanese paediatric patients with allergic rhinitis, eczema/dermatitis, urticaria and pruritus
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All the patients who:
- •haven't treatment experience of epinastine product;
- •have at least one out of following diseases. allergic rhinitis, eczema, dermatitis, pruritus, urticaria
排除标准
- •Alesion® Dry Syrup is contraindicated for the patients with history of hypersensitivity to any ingredients of Alesion® Dry Syrup in package insert. However, it was unknown whether a patient was hypersensitive to the ingredients of the product in almost cases. And this survey was drug utilization study to observe actual use in any patients. Therefore exclusion criteria are not set in the protocol
研究组 & 干预措施
Patients with allergic rhinitis, eczema/dermatitis, urticaria
干预措施: Alesion® (Drug)
结局指标
主要结局
Incidence of adverse drug reactions
时间窗: up to 3 years
classified by Medical Dictionary for Regulatory Activities (MedDRA) terminology
Incidence of adverse drug reactions classified by patient's background/treatment factors
时间窗: up to 3 years
次要结局
- Overall assessment of efficacy by investigator on a 3-point scale(At 12 weeks and 52 weeks)
研究者
相似试验
已完成
不适用
Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With UrticariaUrticariaNCT02238249Boehringer Ingelheim122
已完成
不适用
Postmarketing Surveillance to Investigate the Safety and Efficacy Information of Alesion® TabletRhinitis, Allergic, PerennialNCT02238223Boehringer Ingelheim2,001
已完成
不适用
Effectiveness and Safety in Patients With Crohn´s Disease in Clinical RoutineCrohn's DiseaseNCT01083680AbbVie (prior sponsor, Abbott)4,107
已完成
不适用
Observation of Side Effects and Effectiveness of Desloratadine (Aerius) Syrup in Filipino Children (Study P05634)Rhinitis, Allergic, SeasonalRhinitis, Allergic, PerennialUrticariaNCT00761527Organon and Co2,980
终止
不适用
Protocol for Post Marketing Surveillance of Actilyse VialStrokeNCT02229799Boehringer Ingelheim265